Search for

We are pleased to share that we have appointed two new Trustees to join the Council. These are:  Professor Michael Spedding (Elected Trustee – Industry)  Professor James Ritter (Elected Trustee – Clinical)  They will follow on the work of Elected Trustee – Industry S...

Educational Resources

For undergraduates studying pharmacology related topics during their first degree; medical students and pharmacy students   What you need to apply Confirmation of your status at university. This could be:   Screenshot of your student portal (should included name, co...

You may remember that in the spring, I announced that we had been working on a new project to improve the way we engage with specialist groups across the Society. We have been looking at how we can create new member communities that will allow you to seek and offer support, an...

Standards and guidance for clinical research relating to COVID-19 are urgently needed to ensure trial data are meaningful Currently, many studies that are running are not of high enough quality to generate meaningful data. Standards and guidelines to support properly desig...

Comprehensive pharmacovigilance and pharmacoepidemiology are needed to inform medication use during the COVID-19 pandemic The Society recognises that concerns have been raised about the use of certain medications in the COVID-19 pandemic. Comprehensive pharmacovigilance ...

The work done by the Department of Molecular and Clinical Pharmacology at the University of Liverpool to improve the safety and effectiveness of medicines has led to the university being awarded a Queen’s Anniversary Prize , one of the most prestigious awards in higher educa...

As you would expect, we have been carefully monitoring developments in relation to the COVID-19 (coronavirus) pandemic.   These are unprecedented times and our main aim is to ensure the safety and well-being of our staff and members. We have put a proactive plan in place t...

The Society’s President, Professor Sir Munir Pirmohamed, will join a new independent group to advise on promising new treatments for COVID-19, the government has announced.   The UK COVID-19 Therapeutics Advisory Panel (UK-CTAP) will identify candidate therapeutics for pha...

Financial stability was a critical area of focus throughout 2023 but particularly in the first and second quarter. Publishing income continues to decline due to the impacts of Open Access (OA) on the financial return from all three of the Society’s journals. The Society ha...